Zymogenetics (MM)
   
To register click here

Zymogenetics Stock Price ZGEN

Company Description : A biopharmaceutical company focused on discovering, developing and commercializing therapeutic protein-based products for the treatment of human diseases. url: www.zymogenetics.com

Name:
Zymogenetics (MM)
Symbol:
NASDAQ:ZGEN
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
To register Click hereRegister for free Zymogenetics stock prices.

ZymoGenetics, Merck KGaA start additional phase II/III study of Atacicept : FRANKFURT (Thomson Financial) - ZymoGenetics Inc. said it has started a Phase II/III study testing Atacicept, which it is developing with Germany's Merck KGaA., as a treatment for systemic lupus erythematosus (SLE...

Free Zymogenetics Stock Charts

Zymogenetics Historical Stock Chart
Zymogenetics Historical Stock Chart
Zymogenetics Monthly Stock Chart
Zymogenetics Monthly Stock Chart
Zymogenetics Intraday stock chart
Zymogenetics Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

FREE Company Reports (ZGEN) Free Annual Report - Click Here!

Get the Latest Zymogenetics stock Price, quotes, trades and FREE Zymogenetics stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Zymogenetics (ZGEN) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Zymogenetics News

Latest Zymogenetics News Headlines
DateTimeSource
Headline
06/05/20082:43AMTFNFZymoGenetics, Merck KGaA start additional phase II/III study of Atacicept
05/27/20087:35AMTFNFZymoGenetics gets FDA approval for larger version of Recothrom
05/06/20086:49PMTFNFEarnings roundup: Churchill Downs, ZymoGenetics
04/30/20086:54AMTFNFMerck KGaA launches phase II study on multiple sclerosis drug atacicept
02/13/20087:03PMTFNFZymoGenetics posted 4Q loss narrower than Street view
01/18/20089:38AMTFNFPremarket roundup: Under Armour
01/18/20085:37AMTFNFGerman shares TFN market data at 11.07 am
01/17/20082:19PMTFNFZymoGenetics: FDA OKs Recothrom, triggering $40M milestone payment from Bayer
01/16/20083:22PMTFNFMovers roundup: Owens-Illinois
12/18/20079:31AMTFNFPremarket Movers: Goldman Sachs gains
12/13/20072:40AMTFNFMerck KGaA starts Phase II/III clinical studies of Atacicept in Lupus Nephritis
12/10/20076:56AMTFNFNovo Nordisk associate Zymogenetics posts positive study results for cancer drug

Zymogenetics Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Zymogenetics company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Zymogenetics Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
      USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
34 site:2us nasdaq zgen080706 22:04 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )